Company Description
Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally.
It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions.
This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures.
Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine.
This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway.
It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers.
The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018.
Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
| Country | United States |
| Founded | 1987 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,616 |
| CEO | Massimo Calafiore |
Contact Details
Address: 3451 Plano Parkway Lewisville, Texas 75056 United States | |
| Phone | 214 937 2000 |
| Website | orthofix.com |
Stock Details
| Ticker Symbol | OFIX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000884624 |
| CUSIP Number | 68752M108 |
| ISIN Number | US68752M1080 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Massimo Calafiore | President, Chief Executive Officer and Director |
| Geoffrey C. Gillespie | Chief Accounting Officer |
| Julie B. Andrews | Chief Financial Officer |
| Aviva McPherron | President of Global Operations and Quality |
| Julie D. Dewey | Chief Investor Relations and Communications Officer |
| Jill Mason | Chief Compliance and Risk Officer |
| J. Andres Cedron | Chief Legal Officer and Corporate Secretary |
| Stephanie Walsh | Chief Human Resources Officer |
| Tyler P. Lipschultz | President of Global Biologics |
| Dr. Beau Standish P.Eng., Ph.D. | Chief Enabling Technologies Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 8, 2025 | SCHEDULE 13D/A | Filing |
| May 6, 2025 | 10-Q | Quarterly Report |
| May 6, 2025 | 8-K | Current Report |
| Apr 30, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 30, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 17, 2025 | SCHEDULE 13G/A | Filing |
| Apr 11, 2025 | SCHEDULE 13D/A | Filing |
| Apr 7, 2025 | 8-K | Current Report |
| Mar 12, 2025 | 8-K | Current Report |
| Feb 27, 2025 | SCHEDULE 13D/A | Filing |